drugset / Trial / NCT02125292

Taste Assessment Study of SHP429 in Healthy Adult Subjects

NCT02125292

Phase 1 Completed 18 enrolled Shire
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to compare the palatability of SHP429 capsule contents delivered via 3 means of administration (sprinkled on yogurt, sprinkled on applesauce, and emptied into a cup and administered with water).

Timeline

Start
2014-06-02
Primary completion
2014-06-19
Completion
2014-06-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesalamine Small molecule 500 mg Oral

Indications

No indication recorded.